Senate panel votes on whether to hold Dr. Anthony Fauci in contempt after Fifth Amendment invocation during COVID-era testimony, according to report

A Senate committee is reported to have voted on whether to hold Dr. Anthony Fauci in contempt after he invoked the Fifth Amendment multiple times during a COVID-era hearing, according to a report published Thursday by the New York Post. The article says the vote centers on Fauci’s refusal to answer certain questions under the constitutional privilege against self-incrimination during testimony tied to the committee’s review of COVID-related decisions and actions.

The New York Post report states that Fauci “took the Fifth” 111 times during the hearing that is at issue. It also says the contempt-related charge could carry consequences including up to one year in prison and a $1,000 fine if the matter results in conviction. The report frames those stakes as potential exposure tied to the contempt process rather than a criminal conviction from a courtroom trial within the committee hearing itself.

Under the U.S. congressional contempt framework, a committee vote can be the first step in moving a dispute to the next phase of enforcement, typically through referrals involving congressional authority. Exact procedural timing and whether a contempt citation becomes an actionable case can vary based on the committee’s action and subsequent steps by lawmakers or other officials responsible for carrying the matter forward. This story’s core details about the committee’s vote are attributed to the New York Post, and the full official record of the vote was not provided in the supplied materials.

Fauci, a former public health official who has testified before Congress on COVID and related topics, has previously described the Fifth Amendment invocation as a matter of constitutional protection in the face of questions he believed could expose him to potential legal jeopardy. In the reported committee context, the contempt action would be grounded in lawmakers’ view that the privilege was used excessively or in circumstances where they believe answers were required for oversight purposes, though the report does not supply the specific exchange-by-exchange citations of where questions were asked and answers refused.

If the matter proceeds beyond the committee level, it could raise additional due process questions about how congressional inquiries intersect with Fifth Amendment rights and what evidentiary showing lawmakers believe they are entitled to. It could also prompt further disputes about congressional scope of authority over witnesses’ refusals to answer, and the legal standards governing contempt enforcement.

The practical implications extend beyond a single witness. A contempt pathway can affect congressional oversight strategy, including how committees frame questions, whether they seek documents instead of testimony, and how lawmakers decide when to escalate disputes into formal enforcement steps. It also can become a focal point for broader separation-of-powers debates about legislative oversight, constitutional privileges, and the role of courts or other enforcement mechanisms if the dispute is contested.

For now, the reported committee action is the key development. To confirm the precise nature of the vote, the committee members involved, and the official procedural status of any contempt referral, the next step would be publication or release of the committee’s official vote record and related documents. Without that additional record in the supplied packet, the committee vote and its immediate legal posture remain attributable to the reporting outlet.